Companies /Healthcare
Lilly(Eli) & Company
NYSE: LLY Drug Manufacturers - General
$1,173.38
▼ $9.24 (−0.78%) today
Markets open · 11:55am ET

Eli Lilly (LLY) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
83%
EPS beat rate
+15.09%
Avg. EPS surprise
Consecutive EPS beats
LLY vs Market · 30-day return after each reportLLYS&P 500
−10%0%+10%+20%−5.5%+6.7%Q1 25+17.1%+2.9%Q2 25+23.9%+0.3%Q3 25−8.9%−1.2%Q4 25+13.9%+5.7%Q1 26−1.8%+0.1%Q2 26
−10%0%+10%+20%Q1 25Q3 25Q1 26
LLY EPS Trend · estimate vs actualEstimateActual
$0$3$6$9$3.46$3.34Q1 25$5.59$6.31Q2 25$5.89$7.02Q3 25$6.93$7.54Q4 25$6.79$8.55Q1 26$6.58$8.38Q2 26
$0$3$6$9Q1 25Q3 25Q1 26
LLY Revenue Trend · estimate vs actualEstimateActual
$0$7.0B$14.0B$21.0B$12.7B$12.7BQ1 25$14.7B$15.6BQ2 25$16.1B$17.6BQ3 25$17.9B$19.3BQ4 25$17.8B$19.8BQ1 26$20.7B$23.0BQ2 26
$0$7.0B$14.0B$21.0BQ1 25Q3 25Q1 26

How Often Does Eli Lilly Beat Earnings Estimates?

Eli Lilly beat EPS estimates in 5 of its last 6 reported quarters, and has beaten 5 quarters in a row.

LLY quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $8.38 est. $6.58 +27.27% $23.0B est. $20.7B +11.06%
Q1 2026 $8.55 est. $6.79 +25.88% $19.8B est. $17.8B +11.14%
Q4 2025 $7.54 est. $6.93 +8.73% $19.3B est. $17.9B +7.51%
Q3 2025 $7.02 est. $5.89 +19.15% $17.6B est. $16.1B +9.53%
Q2 2025 $6.31 est. $5.59 +12.89% $15.6B est. $14.7B +6.06%
Q1 2025 $3.34 est. $3.46 −3.39% $12.7B est. $12.7B +0.05%

Figures from SEC filings and company reports. Not investment advice.